Maxim Group downgraded GW Pharma (NASDAQ: GWPH) from Buy to Hold, citing higher risks.Analyst Gabrielle Zhou commented, "GW's rival Zynerba ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE